Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9271978 Heterocyclic compounds as bromodomain inhibitors

Patent 9271978 was granted and assigned to Zenith Epigenetics Corp. on March, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Zenith Epigenetics Corp.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Bryan Cordell Duffy0

Bruce Francis Molino0

Gregory Scott Martin0

He Zhao0

John Frederick Quinn0

May Xiaowu Jiang0

Peter Ronald Young0

Ruifang Wang0

...

Date of Patent

March 1, 2016

0

Patent Application Number

141347930

Date Filed

December 19, 2013

0

Patent Citations Received

US Patent 11773085 Methods and compounds for treating disorders

US Patent 11851445 Compounds and uses thereof

0

US Patent 11787800 BRD9 degraders and uses thereof

US Patent 11767330 Citrate salt, pharmaceutical compositions, and methods of making and using the same

Patent Primary Examiner

0

Patent abstract

The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9271978 Heterocyclic compounds as bromodomain inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool